Loading data
VORNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 321.53 m USD | 93.31 m USD | 94.32 m USD | 64.55 m USD | 47.53 m USD |
| Operating profit | -371.64 m USD | -121.19 m USD | -126.04 m USD | -93.42 m USD | -69.02 m USD |
| Net income (reported basis) | -695.98 m USD | -116.91 m USD | -117.86 m USD | -92.09 m USD | -68.9 m USD |
| Net income attributable to common shareholders | — | — | -117.86 m USD | -92.09 m USD | -70.13 m USD |
| Basic earnings per share | -70.5 USD/share | -34.03 USD/share | -1.75 USD/share | -2.33 USD/share | -2.1 USD/share |
| Diluted earnings per share | -70.5 USD/share | -34.03 USD/share | -1.75 USD/share | -2.33 USD/share | -2.1 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.